Clinical effectiveness, cost effectiveness and clinical utility study (Work Package 2)

WP2 Objectives:

  • Provide evidence of
    • Clinical effectiveness
    • Cost effectiveness to the patient, healthcare system and society
    • Clinical utility
  • Study protocol and ethics documentation development, review and approval
  • Clinical study set up and site training in France, Germany, Spain, the Netherlands and the United Kingdom
  • Recruit and complete 776 patients in the P1vital® PReDicT Test directed treatment and Treatment as Usual arms
  • Author and complete the clinical study reports
  • Produce and submit study publications


WP2 Lead: Dr Michael Browning and Dr Gerry Dawson


WP2 Partners:

  • Cost Effectiveness – Professor Judit Simon at Med­ical Uni­ver­sity of Vienna
  • Clinical Utility – Professor Richard Morriss at MindTech and Dr Sue Brown at Uni­ver­sity of Not­ting­ham
  • Clinical Study Coordination:
    • NHS Primary Care in UK
    • France – Pro­fessor Philip Gor­wood at Hos­pital Sainte-Anne, Paris Descartes Uni­ver­sity
    • Germany – Pro­fessor Jür­gen Deck­ert at Klinikum der Uni­versität Würzburg and Pro­fessor Andreas Reif at Uni­ver­sity Hos­pital Frank­furt
    • Spain – Dr Víctor Pérez Sola at Uni­ver­sity Hos­pital Bar­celona
    • The Netherlands – Dr Dick J. Velt­man at VU Uni­ver­sity Med­ical Centre Ams­ter­dam, GGZ inGeest


Horizon 2020 Emblem